Organon

Today, we pause to give thanks for all the wonderful moments and people in our lives. Whether you’re gathered around a table with loved ones or enjoying a quiet day of reflection, we hope your #Thanksgiving is filled with joy and gratitude. #HappyThanksgiving! 🦃🍂

Cardiovascular disease (CVD) was responsible for 35% of total deaths in women in 2019. Despite its high mortality rate, cardiovascular disease remains understudied, under-recognized, under-diagnosed, and under-treated in women. A World Economic Forum report highlights that current health data often miss key women’s health issues. This lack of data can potentially result in missed opportunities to improve the lives of women and girls, especially in vulnerable groups. It can also lead to underestimating health problems, affecting care and investment in women’s health. For example, women’s pain is often under-treated compared to men’s, leading to worse outcomes. Incomplete data can widen the health gap between men and women. To help close the gap, Organon is working to spark collective action to deliver a new era in healthcare that empowers women globally by investing in research and innovation.

Welcome back to The Birds & The Mes. In this episode, Dr. Christine Greves, a board-certified OB/GYN, talks about the importance of seeing a specialist, like a gynecologist, to help establish a baseline for a teen’s reproductive health. She’ll cover what to expect and how to prepare. #WomensHealth #TheBirdsAndTheMes #Gynecologists #Obstetricians

At Organon, we believe in the power of collaboration to create lasting change. Our Her Plan is Her Power initiative focuses on improving maternal health by partnering with communities around the globe. 🤝🌍 Discover how these partnerships are making a difference and learn more about our commitment to maternal health here: https://ogn.llc/6042W0jfa #HerPlanHerPower #MaternalHealth #CommunityPartnerships #HealthcareInnovation

Every year, RESOLVE: The National Infertility Association’s Night of Hope Gala celebrates strides in advocating for #infertility care and highlights the challenges faced by many, while honoring the passionate individuals and organizations that bring RESOLVE’s mission to life. Organon is committed to championing care equity in fertility. By collaborating with providers, advocates, like RESOLVE, and communities, we are working to elevate fertility awareness and expand resources to help more aspiring parents access the care they deserve. #NOH2024

The Misses of Health Information are here to keep it real. Women often need to juggle roles, responsibilities and pressures which can worsen gaps in pay, health and overall care. Addressing these gaps can potentially help improve women’s lives today, and change how future generations of women receive support. At Organon, we’re committed to bringing awareness, investment, and scientific expertise to the healthcare ecosystem supporting the health of women. #MissesofHealthInformation #MissInformation #MissUnderstood #MissDiagnosis #PayEquity #HealthEquity #WomensHealth

Dr. Charlotte Owens, MD, FACOG, Organon’s Head of Medical Affairs & Outcomes Research, spoke at the #FierceBiotechSummit on the topic of Empowering Women’s Health through Biotech Innovation and Research. The discussion focused on the impact investment in women’s health can have on society as a whole. Increasing awareness of women’s health, including and beyond sexual and reproductive health, can not only help women thrive but also help their families, communities, and economies. Our mini mic team met Dr. Owens afterwards to get her key takeaways. #WomensHealth #Biotech24 Fierce Life Sciences Events

On this International Men’s Day, let’s celebrate the men at Organon who champion gender equality and support the women in their lives. Your dedication to creating an inclusive environment is vital to our vision of a healthier every day for every woman.

#Biosimilars have the potential to play a vital role in making health care more accessible and affordable for people with certain conditions. Learn more about how biosimilars may provide cost-effective alternatives to originator biologics.

Our next feature in “Minds Behind the Science” spotlights Allison Armstrong, PhD, an Asset Development Team Leader at Organon who oversees the strategic development of new therapies.  From early inspirations in science and rare diseases to driving real-world change in women’s health, Allison’s work is centered around empathy, passion, and innovation. Her journey from drug discovery to clinical development began with a pivotal moment early in her career when she attended a patient and family caregiver meeting for rare pediatric metabolic diseases. From that point, her work wasn’t just about the science; it was about the patients living with these diseases every day.  Today, her team is working on a program that aims to bring more treatment options to women with polycystic ovary syndrome (PCOS)—a condition which affects an ‘estimated 8–13% of women of reproductive age, and up to 70% of affected women remain undiagnosed worldwide, according to the World Health Organization (WHO). “Everyone you talk to at Organon has this drive to improve the treatment options available for women’s health conditions,” Allison says. Listen to how her teamwork-centered approach helps drive innovation at Organon, where the focus is always on delivering important therapies to patients around the world. #MindsBehindTheScience #WomenInScience #PolycysticOvarySyndrome #PCOS #WomensHealth